These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38865680)

  • 41. A practice game changer: Impact of tenecteplase for acute ischemic stroke in a multicenter quality improvement project.
    Noh L; Pham F; Haddad L; Burkhard T; Paletz L; Pech M; Lewis M; Manoukian V; Schlick KH; Song S
    Am J Health Syst Pharm; 2022 Apr; 79(9):e149-e153. PubMed ID: 35037028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The promise of tenecteplase in acute stroke: Within reach or beyond approval?
    Zachrison KS; Schwamm LH
    Med; 2022 Oct; 3(10):651-655. PubMed ID: 36202099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tenecteplase utility in acute ischemic stroke patients: A clinical review of current evidence.
    Nelson A; Kelly G; Byyny R; Dionne C; Preslaski C; Kaucher K
    Am J Emerg Med; 2019 Feb; 37(2):344-348. PubMed ID: 30471930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tranexamic acid for treatment of symptomatic hemorrhagic conversion following administration of tenecteplase for acute ischemic stroke.
    Hailu K; Ragoonanan D; Davis H
    Am J Emerg Med; 2022 Sep; 59():216.e1-216.e5. PubMed ID: 35750531
    [No Abstract]   [Full Text] [Related]  

  • 45. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
    Menon BK; Buck BH; Singh N; Deschaintre Y; Almekhlafi MA; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar J; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra S; Gioia LC; Jalini S; Cayer C; Phillips S; Elamin E; Shoamanesh A; Subramaniam S; Kate M; Jacquin G; Camden MC; Benali F; Alhabli I; Bala F; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe A; Sehgal A; Zhang Q; Lethebe BC; Doram C; Ademola A; Shamy M; Kenney C; Sajobi TT; Swartz RH;
    Lancet; 2022 Jul; 400(10347):161-169. PubMed ID: 35779553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tenecteplase for Acute Ischemic Stroke Treatment.
    Baird AE; Jackson R; Jin W
    Semin Neurol; 2021 Feb; 41(1):28-38. PubMed ID: 33472268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety outcomes of Tenecteplase versus Alteplase for thrombolysis of acute ischemic stroke: A meta-analysis of 9 randomized controlled trials.
    Wang Y; Cai X; Fang Q; Zhu J
    J Neurol Sci; 2024 Mar; 458():122912. PubMed ID: 38325064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke.
    Tsivgoulis G; Katsanos AH; Christogiannis C; Faouzi B; Mavridis D; Dixit AK; Palaiodimou L; Khurana D; Petruzzellis M; Psychogios K; Macleod MJ; Ahmed N
    Ann Neurol; 2022 Sep; 92(3):349-357. PubMed ID: 35713213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial.
    Wang Y; Li S; Pan Y; Li H; Parsons MW; Campbell BCV; Schwamm LH; Fisher M; Che F; Dai H; Li D; Li R; Wang J; Wang Y; Zhao X; Li Z; Zheng H; Xiong Y; Meng X;
    Lancet; 2023 Feb; 401(10377):645-654. PubMed ID: 36774935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Dewey HM; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Ang T; Miteff F; Levi CR; Rodrigues E; Zhao H; Salvaris P; Garcia-Esperon C; Bailey P; Rice H; de Villiers L; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Wong AA; Muller C; Coulthard A; Mitchell K; Clouston J; Mahady K; Field D; Ma H; Phan TG; Chong W; Chandra RV; Slater LA; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
    N Engl J Med; 2018 Apr; 378(17):1573-1582. PubMed ID: 29694815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tenecteplase Knocking on the Door.
    Hill MD; Michel P
    Stroke; 2018 Sep; 49(9):2276-2277. PubMed ID: 30018162
    [No Abstract]   [Full Text] [Related]  

  • 52. Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit.
    Bivard A; Zhao H; Coote S; Campbell B; Churilov L; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski A; Dos Santos A; Ng F; Langenberg F; Stephenson M; Smith K; Bernard S; Thijs V; Cloud G; Choi P; Ma H; Wijeratne T; Chen C; Olenko L; Davis SM; Donnan GA; Parsons M
    BMJ Open; 2022 Apr; 12(4):e056573. PubMed ID: 35487712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke.
    Logallo N; Kvistad CE; Nacu A; Naess H; Waje-Andreassen U; Asmuss J; Aamodt AH; Lund C; Kurz MW; Rønning OM; Salvesen R; Idicula TT; Thomassen L
    BMC Neurol; 2014 May; 14():106. PubMed ID: 24886064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tenecteplase versus alteplase in stroke thrombolysis: the last piece of the puzzle?
    Toyoda K
    Lancet Neurol; 2024 Aug; 23(8):750-751. PubMed ID: 38880117
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial.
    Singh N; Almekhlafi MA; Bala F; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Buck B; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Ghrooda E; Poppe AY; Williams H; Field TS; Manosalva A; Siddiqui MM; Zafar A; Imoukhoude O; Hunter G; Shamy M; Demchuk AM; Claggett BL; Hill MD; Sajobi TT; Swartz RH; Menon BK
    Stroke; 2023 Nov; 54(11):2766-2775. PubMed ID: 37800372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial.
    Bivard A; Zhao H; Churilov L; Campbell BCV; Coote S; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski AH; Dos Santos A; Ng JL; Yogendrakumar V; Ng F; Langenberg F; Easton D; Warwick A; Mackey E; MacDonald A; Sharma G; Stephenson M; Smith K; Anderson D; Choi P; Thijs V; Ma H; Cloud GC; Wijeratne T; Olenko L; Italiano D; Davis SM; Donnan GA; Parsons MW;
    Lancet Neurol; 2022 Jun; 21(6):520-527. PubMed ID: 35525251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tenecteplase in Acute Stroke: What About the Children?
    Sun LR; Wilson JL; Waak M; Kiskaddon A; Goldenberg NA; Jordan LC; Barry M
    Stroke; 2023 Jul; 54(7):1950-1953. PubMed ID: 37226774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of tenecteplase in comparison to alteplase in acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Salamatullah HK; Bashrahil B; Alghamdi AM; Alsharm FS; Alkulli OA; Alzahrani Z; Alkhiri A; Alghamdi S; Makkawi S
    Clin Neurol Neurosurg; 2023 Oct; 233():107961. PubMed ID: 37713743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial.
    Kvistad CE; Næss H; Helleberg BH; Idicula T; Hagberg G; Nordby LM; Jenssen KN; Tobro H; Rörholt DM; Kaur K; Eltoft A; Evensen K; Haasz J; Singaravel G; Fromm A; Thomassen L
    Lancet Neurol; 2022 Jun; 21(6):511-519. PubMed ID: 35525250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Off-label tenecteplase use in spinal cord ischemia.
    Oliveira DS; Sousa L
    Acta Neurol Belg; 2023 Dec; 123(6):2409-2412. PubMed ID: 36892749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.